SS-31 (Elamipretide) requires stringent analytical validation via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry to ensure sequence fidelity and quantitative purity. As a specialized mitochondria-targeted tetrapeptide, high-purity SS-31 is critical for generating reproducible data in preclinical bioenergetic and oxidative-stress research.
SS-31 (Elamipretide) requires stringent analytical validation via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry to ensure sequence fidelity and quantitative purity. As a specialized mitochondria-targeted tetrapeptide, high-purity SS-31 is critical for generating reproducible data in preclinical bioenergetic and oxidative-stress research.
SS-31 HPLC analysis employs reverse-phase high-performance liquid chromatography (RP-HPLC) paired with UV detection at 214 nm and 280 nm to verify the chemical purity and sequence fidelity of the mitochondria-targeted tetrapeptide SS-31 (Elamipretide). High RP-HPLC purity (>99%) eliminates truncated peptide fragments and synthesis side-products, ensuring predictable cardiolipin binding dynamics and reproducible bioenergetic data in preclinical laboratory research.
When evaluating synthetic peptides for laboratory protocols, liquid chromatography serves as the gold standard for quantitative purity determination. For researchers utilizing the SS-31 research compound, RP-HPLC separates the target sequence (D-Arg-Dmt-Lys-Phe-NH2) from closely related impurities, such as deletion sequences, racemized species, and incomplete deprotection byproducts generated during solid-phase peptide synthesis (SPPS).
SS-31 is a synthetically engineered aromatic-cationic tetrapeptide designed to selectively target and concentrate within the inner mitochondrial membrane (IMM). Preclinical studies indicate that the peptide's unique sequence motif enables it to interact directly with cardiolipin, an essential phospholipid predominant in the IMM that governs cristae structure, electron transport chain (ETC) supercomplex organization, and membrane potential integrity.
In vitro models demonstrate that SS-31 binds to cardiolipin via electrostatic and hydrophobic interactions. By stabilizing cardiolipin, the peptide prevents pathological lipid peroxidation, preserves cristae curvature, and maintains optimal activity of respiratory Complexes I, III, and IV. Consequently, researchers investigating cellular energy production frequently measure parameters such as ATP production rates, oxygen consumption rate (OCR), and mitochondrial reactive oxygen species (ROS) emissions in response to SS-31 exposure.
Because cardiolipin interactions depend on the exact spatial orientation and charge distribution of the tetrapeptide, presence of impurities or altered peptide sequences can significantly alter binding affinity. This highlights why verified peptide purity testing is indispensable prior to initiating quantitative in vitro or ex vivo assays.
High-performance liquid chromatography operates by partitioning analyte molecules between a stationary phase (typically a silica-based C18 column) and a mobile phase consisting of water, acetonitrile, and ion-pairing modifiers such as trifluoroacetic acid (TFA). As the gradient progresses, SS-31 elutes at a characteristic retention time based on its specific hydrophobicity profile.
While RP-HPLC quantifies the relative peak area of the primary peptide relative to total integrated peaks, tandem Mass Spectrometry (MS) or Electrospray Ionization Mass Spectrometry (ESI-MS) provides definitive molecular weight verification. For SS-31, ESI-MS confirms the exact monoisotopic or average mass corresponding to the expected sequence (MW ~639.8 g/mol for the free base).
Combining RP-HPLC peak quantification with MS mass verification ensures that a given batch of research peptides contains no co-eluting isobaric impurities or structural isomers that could skew preclinical experimental readouts.
A rigorous SS-31 HPLC analytical report must display a sharp, symmetrical main peak with minimal tailing. The peak symmetry factor (typically targeted between 0.8 and 1.2) reflects optimal chromatographic efficiency and correct mobile-phase conditioning.
Analytical chemists determine total peptide purity by calculating the area under the curve (AUC) for the main SS-31 peak as a percentage of the total integrated area across the run duration. Any minor peaks appearing prior to or after the main peak represent hydrophilic (e.g., short deletion sequences) or hydrophobic (e.g., unremoved protecting groups) contaminants, respectively. Laboratory researchers should demand a total main-peak AUC exceeding 99.0% for sensitive bioenergetic studies.
PX1 Research enforces strict quality assurance protocols for every lot of SS-31. Synthetic production occurs exclusively within domestic, GMP-compliant facilities adhering to rigorous quality management frameworks. Every batch undergoes mandatory independent testing by an ISO 17025 accredited laboratory to verify sequence identity and purity via RP-HPLC and ESI-MS.
In addition to purity metrics, preclinical applications—particularly primary cell cultures, isolated mitochondrial assays, and animal models—require stringent control over bacterial endotoxins. PX1 Research subjects all lot batches to Chromogenic Reagent Endotoxin Testing (LAL assay) to guarantee endotoxin levels remain below strict limits (<0.01 EU/mg).
Every shipment includes a comprehensive, lot-specific Certificate of Analysis (COA) detailing raw HPLC chromatograms, mass spectra, and endotoxin assay outcomes. Combined with same-day shipping M–F from fulfillment hubs in California and Arizona, institutional researchers receive verified compounds with total supply chain transparency. Laboratories managing multi-phase studies can also access our wholesale account portal for bulk procurement and custom lot reservations.
Mitochondrial biology and cellular stress research frequently utilize distinct classes of peptide compounds targeting bioenergetic pathways. While SS-31 acts directly on cardiolipin within the inner mitochondrial membrane to optimize electron transfer, other mitochondrial research compounds operate through nuclear signaling or mitochondrial-derived peptide pathways.
For instance, researchers comparing mitochondrial-derived signaling factors often evaluate the MOTS-c research peptide, which translocates to the nucleus during metabolic stress to regulate nuclear gene expression, as detailed in our analysis of MOTS-c purity standards. Similarly, the mitochondrial-derived peptide Humanin is investigated for cytoprotective mechanisms against oxidative stress and apoptotic cascades. In contrast to signaling peptides, SS-31 acts primarily as a structural and functional restorer of the cardiolipin-dependent membrane microenvironment, making it a unique tool in electron transport chain research.
Lyophilized SS-31 trifluoroacetate salt is highly soluble in aqueous media due to its basic basic amino acid residues (D-arginine and lysine). For in vitro cell culture and isolated organelle assays, standard reconstitution protocols involve dissolving the lyophilized powder in sterile, deionized water or phosphate-buffered saline (PBS, pH 7.4).
To ensure precise concentration dosing in microplate bioenergetic assays (e.g., Seahorse XF analyzers), stock solutions should be prepared using calibrated volumetric equipment under sterile laminar flow hoods. When preparing stock solutions for cell culture, researchers must factor in the total peptide content (accounting for residual counterions and water content) rather than gross dry weight alone.
Proper storage conditions are mandatory to prevent hydrolytic degradation or peptide oxidation over time. Lyophilized SS-31 should be stored desiccated at -20°C or -80°C upon receipt, where it maintains chemical stability for up to 24 months.
Once reconstituted into aqueous solution, aliquots should be divided into single-use working volumes and stored at -80°C to minimize repeated freeze-thaw cycles. Freeze-thaw cycling accelerates physical aggregation and potential peptide bond cleavage. Reconstituted stock solutions stored at 4°C should generally be utilized within 24 to 48 hours to ensure chemical stability during in vitro experiments.
Navigating compound sourcing for academic, biotechnology, or pharmaceutical research requires suppliers offering verifiable analytical documentation. Substandard or unverified peptides introduce experimental confounders, leading to non-reproducible cell viability or oxygen consumption data.
PX1 Research provides fully documented, US-manufactured compounds designed strictly for laboratory research use. Explore our complete library of research materials or review our all-peptides catalog to view comprehensive specifications, safety data sheets, and representative HPLC/MS analytical spectra.
What does an ss-31 hplc chromatogram demonstrate?
An SS-31 HPLC chromatogram displays the relative purity of the peptide sample by separating the primary SS-31 molecule from synthesis impurities based on hydrophobic interactions. The single dominant peak's area under the curve (AUC) divided by the total integrated peak area yields the percentage chemical purity.
Why is high purity crucial for SS-31 cardiolipin binding assays?
SS-31 relies on specific electrostatic and hydrophobic interactions to bind cardiolipin at the inner mitochondrial membrane. Truncated peptide sequences or chemical contaminants can competitively inhibit this binding or yield false-positive/negative readouts in electron transport and ATP production assays.
What mass spectrometry methods verify SS-31 identity?
Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) mass spectrometry are standard methods used to confirm the exact molecular weight (~639.8 g/mol) and charge states of SS-31, matching its theoretical amino acid composition.
How should SS-31 be reconstituted for in vitro electron transport studies?
Lyophilized SS-31 should be reconstituted in sterile water or buffered saline (such as PBS, pH 7.4) under sterile conditions. Aliquots should be prepared immediately to avoid multiple freeze-thaw cycles before introduction to isolated mitochondria or cell cultures.
What is the recommended long-term storage temperature for lyophilized SS-31?
Lyophilized SS-31 powder should be stored desiccated at -20°C or -80°C for long-term stability. Under these conditions, the peptide remains stable for up to 24 months.
What are the acceptable endotoxin limits for SS-31 in laboratory cell culture?
For sensitive cell culture and in vitro mitochondrial assays, endotoxin levels should ideally measure below 0.01 EU/mg. PX1 Research verifies endotoxin content for every lot via LAL testing to prevent endotoxin-induced inflammatory artifacting.
What molecular targets does SS-31 interact with at the inner mitochondrial membrane?
Preclinical evidence confirms that SS-31 selectively targets cardiolipin, a polyunsaturated phospholipid localized to the inner mitochondrial membrane, helping preserve cristae structure and respiratory chain supercomplexes.
How does SS-31 compare to MOTS-c in mitochondrial research models?
While SS-31 acts directly as a membrane-stabilizing agent targeting cardiolipin inside the mitochondria, MOTS-c is a mitochondrial-derived peptide that functions primarily as a signaling factor regulating nuclear metabolic gene expression under cellular stress.
How does PX1 Research guarantee lot-to-lot SS-31 quality?
PX1 Research subjects every batch of US-manufactured SS-31 to independent third-party analysis at ISO 17025 accredited facilities. Each lot receives a public Certificate of Analysis detailing RP-HPLC purity, ESI-MS identity, and endotoxin levels.
Can bulk or institutional lab orders be fulfilled with custom purity documentation?
Yes, academic institutions and commercial laboratories purchasing through PX1 Research can access bulk quantities, dedicated lot reservations, and full analytical raw data packages via our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.